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Abstract
Background: The repeated measures in the Framingham Heart Study in the Genetic Analysis
Workshop 13 data set allow us to test for consistency of linkage results within a study across time.
We compared regression-based linkage to variance components linkage across time for six
quantitative traits in the real data.
Results: The variance components approach found 11 significant linkages, the regression-based
approach found 4. There was only one region that overlapped. Consistency between exams
generally decreased as the time interval between exams increased. The regression-based approach
showed higher consistency in linkage results across exams.
Conclusion: The low consistency between exams and between methods may help explain the lack
of replication between studies in this field.
Background
The general lack of replication of genome scan results
across data sets is an ongoing concern in statistical genet-
ics [1]. Consistency (or lack thereof) within a single study
with longitudinal data could provide insight into the
problem of replication. The repeated measures in the
Framingham Heart Study in the Genetic Analysis Work-
shop 13 (GAW13) data set allow us to test for consistency
of linkage results within a study across time. We believe
that advances in simulation have not reached the point
that they adequately capture the underlying complexity
that contributes strongly to consistency issues. We there-
fore chose to use the real data.
A new regression-based method of linkage analysis that
works on arbitrary pedigrees has recently been published
[2] and implemented in the publicly available MERLIN
software package [3]. This method promises to be robust
with respect to departures from normality, a problem that
has plagued variance components linkage analysis [4]. We
used MERLIN to perform linkage analysis using both var-
iance components (VC) and regression-based linkage
analysis on seven quantitative traits in the real data from
the Framingham Heart Study. For six of these traits, mul-
tiple observations (three or four for each trait) were avail-
able across time for all family participants. We performed
linkage analysis using both methods on each of these time
points. Thus, we performed 23 genome scans using each
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method (46 total) in MERLIN. This allowed us to compare
results across methods and across exams. To validate the
MERLIN VC we also performed genome scans on the 23
quantitative traits using GENEHUNTER [5] to compare
the VC implementations.
Methods
The traits we analyzed were body mass index (BMI), total
cholesterol (CHOL), glucose (GLU), high-density lipo-
protein cholesterol (HDL), height (HGT), systolic blood
pressure (SBP), and log-transformed triglycerides (LGTG).
The effects of sex, age, age2, and cohort status were
included as covariates in all genome scans. In order to test
the robustness of regression-based linkage, we did not
transform any of the variables to achieve normality
(except triglycerides). To maintain as much consistency
across data sets as possible, we did not correct for hyper-
tension, diabetes, or any medication.
The 330 families were trimmed using the PEDSYS
PEDTRIM program. This program removes individuals
from a pedigree who do not contribute any phenotypic or
genotypic information. Using the criterion of at least one
marker on chromosome 22, PEDTRIM reduced the family
set from 4692 individuals in 330 families to 2604 individ-
uals in 334 families (trimming caused four families to
each be split into two).
The complexity of a family is measured by the formula
2N-F, where N is the number of nonfounders and F is the
number of founders. Our prior experience with GENE-
HUNTER indicates that a practical upper limit for the
complexity of a family is 21. After trimming, there were
still nine families with complexity greater than 21 (range
23–46). These nine families were cut into 19 separate ped-
igrees, resulting in 2588 individuals in 344 families. All
analyses described in this report used these trimmed and
cut family structures.
We constructed four data sets (denoted A-D) by filling out
the families with data corresponding to the first four
Cohort 2 exams and include individuals from Cohort 1
exams that overlapped in time with the four Cohort 2
exams, thus yielding four data sets, each with paired con-
temporaneous data for Cohorts 1 and 2. These four "cross-
sectional" data sets represent four time points spanning
approximately 16 years. For data set A, the variables were
taken from Cohort 2 Exam 1 and Cohort 1 Exam 12,
depending on the cohort of the individual. Cohort 2 Exam
1 and Cohort 1 Exam 12 overlap in time (1970–1971)
and are thus the natural choice to achieve a cross-sectional
data set of these families. Similarly, for data sets B through
D, we combined Cohort 2 Exam 2 and Cohort 1 Exam 16
(1978–1979), Cohort 2 Exam 3 and Cohort 1 Exam 18
(1982–1983), and Cohort 2 Exam 4 and Cohort 1 Exam
20 (1986–1987), respectively. There were several excep-
tions to this scheme. There were no Cohort 1 Exams 16 or
18 for cholesterol and HDL, so data set C was not con-
structed for either trait and data set B used data from
Cohort 1 Exam 15 rather than 16. Similarly, height was
not available from Cohort 1 Exam 12, so both height and
BMI data sets A were constructed using data from Cohort
1 Exam 10.
We performed VC linkage analysis on all 23 traits using
GENEHUNTER and MERLIN. Both programs computed
multipoint identity-by-descent (IBD) probabilities at each
marker and at four equally spaced loci between each pair
of markers. We also performed regression-based linkage
analysis [2] on all 23 traits using MERLIN.
Results
MERLIN computed IBD probabilities much faster than
GENEHUNTER (approximately 4.5 times faster on our
Pentium 4 computer). A full genome scan (including IBD
calculations) on MERLIN took approximately 4.5 hours
for VC linkage and 41 hours for regression-based linkage.
In addition, MERLIN was limited to markers with less
than 32 alleles (on our 32-bit system). One marker had 39
alleles; it was downcoded to 30 alleles.
Table 1 shows basic descriptive statistics for all the quan-
titative traits over all available data sets. The last letter in
each trait name refers to the particular data set (A-D). The
Framingham Heart Study can be considered a population-
based sample, so the mean, variance (SD2), and heritabil-
ity in this table were used as input to the regression-based
linkage analyses. Heritability was computed by MERLIN
as the ratio of additive polygenic variance to the total
variance.
Table 2 shows all maximum LOD scores greater than 1.44
(p < 0.005) for VC and regression. For every LOD score
greater than 1.44, the LOD score at the same point using
the other method is included for comparison. For each
trait, the LOD scores are ordered by chromosome, centi-
morgan location, and data set, in that order. There were
15 distinct regions for which one or the other method
found a LOD score greater than 3.0 in at least one exam.
VC analysis found 11 regions, regression found 4 regions,
and there was one region in which both methods found
significant linkage (chromosome 7 for cholesterol). Of
the 11 significant regions from VC, 8 had some support-
ing evidence for linkage (LOD score > 1.0) from regres-
sion. Of the 4 significant regions from regression, 2
showed supporting evidence from VC. Perhaps surpris-
ingly, of the 5 significant regions for which the other
method did not provide some support, 4 were for height.
The last line of Table 2 shows for each trait the LOD score
correlation between the two methods. The correlation
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calculation used all LOD scores over all loci on every chro-
mosome and all available data sets (there were 1917 LOD
scores in each genome scan).
VC LOD scores from GENEHUNTER were compared to
VC results from MERLIN. For all traits examined the cor-
relation between LOD scores from the two programs was
at least 0.993. For 18 of the 23 traits the correlation was
0.9999. All p-values were highly significant (p < 0.0001).
The glucose A data set, which had the highest kurtosis, was
a special problem for regression-based linkage. The pro-
gram gave no LOD score at all between 180 and 190 cM
on chromosome 4, and it gave a LOD score of 12.5 at 1 cM
on chromosome 3. In both cases, it gave heritabilities
greater than 1. For these reasons, we exclude the glucose A
data set from further consideration. In addition, results
from MERLIN for weight were obviously incorrect (herit-
abilities of 1.0 and all LOD scores were 0.0), so we do not
report any results for weight. The reasons for this anomaly
are currently unknown to us.
Table 3 shows the correlation between pairs of traits for all
traits analyzed. The results conform to prior expectation;
the highest correlations are within those traits that have
the smallest measurement error (height and BMI). Also,
the lowest correlations are between the two data sets (A
and D) that are the farthest apart in time.
Table 4 shows the MERLIN VC LOD score correlations
between all possible pairs of data sets. For cholesterol and
HDL, data set C was missing, so correlations are not avail-
able for pairs involving data set C. In general, the highest
correlations were for BMI and height and the lowest cor-
relations were for glucose and SBP. In addition, there was
a crudely inverse relationship between time interval and
correlation; i.e., higher correlations were observed when
the time interval between exams was smaller (B-C and C-
D) and lower correlations were observed when the time
interval was larger (A-D).
Table 5 shows the regression-based LOD score correla-
tions between all possible pairs of data sets. The overall
pattern among traits is very similar to VC, i.e., higher cor-
relations for BMI and height and lower correlations for
glucose and SBP. However, the exam-to-exam consistency
is much higher for regression-based linkage, often twice as
high.
Discussion
Two obvious differences between the two methods are the
number of significant linkage regions and the improved
consistency in LOD scores between data sets provided by
the regression-based approach as opposed to the variance
components approach. VC analysis found almost three
times as many significant regions as regression-based link-
age. This may be due to the well known inflation of LOD
Table 1: Descriptive statistics for all traits
Trait N Mean SD Range h2 Skewness Kurtosis
BMI_A 1931 25.417 4.194 14 – 53 0.348 0.797 1.819
BMI_B 1765 25.950 4.362 15 – 51 0.388 0.932 1.912
BMI_C 1679 26.273 4.605 11 – 49 0.375 0.989 1.993
BMI_D 1680 26.833 4.846 14 – 56 0.458 1.153 2.595
CHOL_A 1319 190.965 37.964 96 – 346 0.616 0.509 0.293
CHOL_B 1779 209.465 41.812 104 – 418 0.480 0.570 0.673
CHOL_D 1666 207.383 39.335 87 – 396 0.382 0.560 0.955
GLU_A 1976 104.482 20.679 64 – 417 0.129 5.340 53.027
GLU_B 1691 96.186 25.788 47 – 369 0.058 5.362 42.922
GLU_C 1656 96.172 31.991 57 – 487 0.202 6.176 49.620
GLU_D 1674 96.884 30.168 42 – 421 0.109 5.237 35.067
HDL_A 1309 50.665 14.200 16 – 118 0.499 0.719 0.905
HDL_B 1760 48.768 13.485 16 – 114 0.468 0.707 0.722
HDL_D 1662 48.973 14.569 19 – 129 0.456 0.876 1.133
HGT_A 1931 65.822 3.953 49 – 78 0.826 0.092 -0.145
HGT_B 1765 65.725 4.077 54 – 78 0.828 0.136 -0.476
HGT_C 1691 65.912 3.968 55 – 78 0.808 0.129 -0.485
HGT_D 1680 65.851 3.985 55 – 78 0.861 0.086 -0.442
LGTG_A 1318 4.311 0.605 2.5 – 6.7 0.434 0.312 0.222
SBP_A 2049 126.276 19.235 78 – 205 0.227 0.937 1.107
SBP_B 1773 125.438 18.300 82 – 203 0.238 0.680 0.548
SBP_C 1729 126.586 19.335 78 – 201 0.282 0.709 0.569
SBP_D 1718 129.219 21.790 80 – 237 0.267 0.871 1.344
BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S30
Page 4 of 6
(page number not for citation purposes)
scores due to non-normality, and indeed two of the signif-
icant VC linkages were detected in glucose, which has high
kurtosis. However, the other eight significant VC linkages
are in traits with low kurtosis (see Table 1). This may indi-
cate that regression-based linkage is conservative. The
higher consistency between data sets from the regression-
Table 2: All LOD scores greater than 1.44 (p < 0.005) for VC and regression-based (REG) linkage
BMI CHOLESTEROL GLU
COS
E
HEIGHT SBP
Chr# 
/set
cM VC 
LOD
REG 
LOD
Chr# 
/set
cM VC 
LOD
REG 
LOD
Chr# 
/set
cM VC 
LOD
REG 
LOD
Chr# 
/set
cM VC 
LOD
REG 
LOD
Chr# 
/set
cM VC 
LOD
REG 
LOD
1/C 96.8 1.63 1.06 1/D 75.2 1.14 1.81 1/C 16.0 1.48 0.44 1/A 16.0 2.96 0.03 1/D 192.0 1.48 1.49
2/A 253.8 1.79 1.12 1/A 75.6 2.15 2.09 1/D 196.0 1.12 1.46 1/A 114.0 0.49 2.29 1/D 208.0 2.28 0.57
3/D 170.6 1.67 1.45 1/A 76.0 2.25 2.09 1/D 222.8 1.23 1.80 1/A 265.4 1.78 0.01 2/D 38.0 3.01 0.29
3/D 179.0 1.52 1.10 1/B 76.0 2.51 1.79 1/B 270.8 0.25 1.53 2/C 59.2 1.58 0.10 2/D 87.8 1.59 1.04
3/D 185.6 1.58 0.87 2/B 125.0 1.08 1.55 2/B 12.4 0.37 2.16 2/C 82.2 1.77 -0.01 2/C 126.6 0.42 1.63
3/D 216.0 1.49 1.30 2/B 145.8 1.19 1.53 2/C 114.0 2.34 0.70 3/A 201.0 2.70 0.10 5/C 25.6 1.88 1.72
3/A 225.0 1.38 1.73 5/B 85.0 1.47 1.11 2/D 122.8 1.01 1.47 5/A 43.0 0.38 1.56 5/C 28.2 1.79 1.88
3/D 225.0 1.41 1.59 7/A 51.6 3.46 1.76 2/D 140.2 1.17 2.42 6/A 25.0 4.35 0.08 5/A 40.0 1.63 0.51
4/B 93.0 1.52 1.16 7/D 54.8 2.16 1.18 2/D 148.2 1.27 1.44 6/A 146.0 1.78 0.85 5/C 53.4 1.53 0.30
6/B 139.6 2.62 1.24 7/D 100.2 3.70 3.40 2/C 237.0 1.46 0.81 6/A 153.2 1.11 1.46 6/C 157.2 2.14 0.09
6/C 141.2 2.60 1.73 7/D 104.6 3.98 3.00 3/D 119.0 1.11 1.77 6/A 184.6 3.01 0.56 7/C 152.0 1.51 1.16
6/C 142.8 2.54 1.74 8/B 26.0 1.85 1.10 5/C 23.0 1.80 0.36 7/A 70.0 1.53 0.51 7/C 167.4 1.47 0.65
6/A 146.0 4.97 2.27 11/D 147.0 1.75 2.55 5/C 45.0 1.63 0.25 7/D 182.0 0.37 1.73 7/B 174.0 1.54 0.47
6/A 147.8 5.03 2.23 11/D 148.0 1.75 2.60 5/C 85.0 2.73 0.74 8/B 26.0 0.06 1.99 8/D 37.0 2.37 2.17
8/B 30.4 2.58 0.59 12/B 61.4 0.45 1.89 5/C 175.0 2.11 0.33 8/C 26.0 0.32 2.74 8/D 38.4 2.23 2.17
8/C 32.6 2.09 0.58 15/D 35.8 1.52 1.08 7/C 79.0 3.01 1.07 8/D 26.0 0.31 3.11 8/A 44.0 1.47 0.28
11/B 117.0 3.18 2.60 18/A 16.0 1.34 1.49 7/C 163.0 1.70 0.36 8/B 56.8 0.41 2.30 12/A 32.0 0.15 1.59
11/B 119.0 3.24 2.48 19/D 70.0 2.48 2.10 8/C 1.0 1.45 0.31 9/A 57.2 1.52 1.36 12/A 41.2 0.14 1.63
16/A 45.4 1.13 2.14 19/D 74.0 2.84 1.85 11/C 76.0 2.13 0.41 9/C 58.0 1.62 1.69 12/B 65.8 1.21 3.28
16/B 55.2 1.86 2.40 19/D 82.0 2.49 1.80 18/C 41.0 2.22 0.36 9/A 59.6 1.04 1.45 14/D 56.0 1.49 1.03
16/B 65.6 2.07 2.13 20/D 33.0 1.83 1.93 18/C 89.0 1.80 0.22 9/C 64.4 0.77 2.34 15/C 60.0 0.98 1.70
20/D 34.2 1.90 1.90 19/C 78.0 2.70 1.70 9/D 80.0 0.97 1.46 15/B 68.0 1.07 1.61
Corr 0.71979 20/A 35.4 1.51 1.59 19/C 101.0 1.60 0.99 10/D 161.6 0.19 1.49 15/D 122.0 1.30 2.05
21/B 7.0 1.95 1.47 22/C 46.0 3.99 1.56 12/A 83.0 1.67 0.06 19/B 10.0 1.50 0.79
HDL 21/B 11.0 1.72 1.58 12/B 85.4 1.90 0.00 19/D 14.4 1.54 0.63
1/B 8.8 1.91 0.86 Corr 0.53719 13/A 55.0 2.05 0.06 19/D 42.0 1.53 0.26
2/A 131.4 2.09 0.99 Corr 0.79113 14/D 126.0 2.42 0.18 22/B 25.0 0.89 2.38
6/A 136.2 3.00 2.35 17/A 63.0 0.34 2.23
7/D 51.6 1.76 1.09 LGTG 17/B 84.8 0.36 3.22 Corr 0.51023
7/D 67.6 2.18 1.22 2/A 48.0 1.52 0.73 17/D 86.2 0.11 2.37
10/B 19.0 1.74 1.30 7/A 67.6 0.83 1.56 17/C 87.6 0.53 4.28
17/D 120.6 0.18 1.91 18/A 105.4 0.89 1.78 18/A 28.0 2.13 0.39
19/D 78.0 1.46 1.33 20/A 42.6 3.43 2.30 18/A 98.2 1.75 0.14
20/A 44.4 3.58 2.27 19/B 23.4 0.23 2.08
Corr 0.64385 19/A 25.8 0.75 1.72
Corr 0.71896 20/A 62.0 1.69 0.34
Corr 0.21209
Table 3: Correlations of trait values across all pairs of data sets
Trait A-B B-C C-D A-C B-D A-D
BMI 0.83118 0.88684 0.89639 0.78071 0.85963 0.74361
CHOL 0.71958 NA NA NA 0.67309 0.62801
GLU 0.29413 0.49062 0.55675 0.39816 0.45167 0.35927
HDL 0.67414 NA NA NA 0.72461 0.66024
HGT 0.94391 0.96608 0.96617 0.90895 0.97801 0.92227
SBP 0.64297 0.71147 0.74963 0.57700 0.67214 0.52960
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based approach supports the previously reported robust-
ness of this method [2]. It should be noted, however, that
the consistency for some traits (e.g., SBP) remains low.
Glucose, which has high kurtosis, is an especially interest-
ing test of the regression method. The VC LOD scores do
not appear to be excessive, however, the regression LOD
scores are generally lower, overall. The much weaker cor-
relations between exams from VC analysis reconfirms
again that VC is sensitive to non-normality. Indeed, given
the low trait correlations for glucose (see Table 3), the
consistency of the regression method is quite good.
The lack of consistency between exams is somewhat dis-
appointing. Table 2 shows only four regions in which at
least three of the four exams had LOD scores greater than
1.44. With the possible exception of height, Tables 4 and
5 confirm the poor consistency between exams. However,
the consistency between exams may also be affected by
the varying sample size from exam to exam. In addition,
the individuals dropping out of the study due to death are
more likely to be older. The effect of sample size and drop-
out bias needs to be investigated further.
The consistency measure used here, correlation between
LOD scores, is problematic. The distribution of LOD
scores from any two exams is clearly not distributed as a
bivariate normal. However, the pattern observed across
time, lower correlations across longer time periods, which
corresponds to expectations, somewhat ameliorates this
concern. Clearly, more work is needed to develop a valid
measure of consistency.
The height results are puzzling. Each method found two
significant linkages, but neither method gave any support
to the significant linkages found by the other method. A
closer examination of the height results reveals that this
inverse relationship exists for the suggestive linkages as
well. The LOD score correlation between methods for
height (0.21) is less than half the next lowest (0.51 for
SBP). Height is unique in this study in at least two ways,
much higher heritability than the other traits and the
assortative mating for height in humans. However, it is
not clear why either of the two methods should be sensi-
tive to these unique aspects of height. In addition, kurtosis
for height is negligible and the highest LOD score from
both methods have some support from previously
reported genome scans (e.g., Hirschhorn et al. [6]), thus
there seems to be little reason to prefer one method to the
other.
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